fut-3 Antibody

What is FUT-3 and what is its biological significance in research applications?

FUT-3 (Fucosyltransferase 3) is an enzyme belonging to the fucosyltransferase family that catalyzes the addition of fucose to precursor polysaccharides in the final step of Lewis antigen biosynthesis. It possesses dual enzymatic activities: alpha(1,3)-fucosyltransferase and alpha(1,4)-fucosyltransferase. The enzyme is responsible for producing fucosylated glycosphingolipids that are synthesized by exocrine epithelial cells and circulate in body fluids. These glycosphingolipids play crucial roles in embryogenesis, tissue differentiation, tumor metastasis, inflammation, and bacterial adhesion . FUT-3 is particularly significant in research because its expression is associated with the Lewis blood group phenotype, making it valuable for studies in glycobiology, cancer research, and immunology .

What are the different types of FUT-3 antibodies available for research and when should each be used?

FUT-3 antibodies are available in multiple formats depending on experimental requirements:

Different antibodies target specific regions of FUT-3, including AA 1-100, AA 83-187, AA 199-361, and AA 288-315 . Selection should be based on the specific experimental application and the epitope accessibility in your experimental conditions. For applications requiring high specificity such as localization studies, monoclonal antibodies are preferable, while polyclonal antibodies may provide greater sensitivity for detection of denatured proteins in Western blotting .

How can I verify the specificity of my FUT-3 antibody?

A methodological approach to validating FUT-3 antibody specificity includes:

• Western blot analysis to confirm detection of a protein at the expected molecular weight (observed at approximately 50 kDa despite calculated MW of 42 kDa due to post-translational modifications)

• Use of positive control lysates from known FUT-3 expressing cells such as A-549, HT-29, 293T, or LO2

• Knockdown or knockout validation using siRNA, shRNA, or CRISPR-Cas9 to demonstrate reduced signal

• Peptide competition assays where pre-incubation with the immunizing peptide should abolish specific binding

• Cross-validation using multiple antibodies targeting different epitopes of FUT-3

• Comparison with functional assays measuring fucosyltransferase activity

What are the optimal conditions for Western blot detection of FUT-3?

For successful Western blot detection of FUT-3, follow these methodological guidelines:

• Sample preparation: Extract total protein using RIPA buffer supplemented with protease inhibitors

• Protein loading: 20-50 μg of protein per lane is typically sufficient

• Gel selection: 10-12% SDS-PAGE gels provide optimal separation

• Transfer: PVDF membranes are preferred for glycoproteins like FUT-3

• Blocking: 5% non-fat milk in TBST for 1 hour at room temperature

• Primary antibody: Dilute according to manufacturer recommendations (typically 1:500-1:2000) and incubate overnight at 4°C

• Detection: Expect FUT-3 to appear at approximately 50 kDa (rather than calculated 42 kDa) due to glycosylation and other post-translational modifications

• Controls: Include positive control lysates from A-549, HT-29, 293T, or LO2 cells

Troubleshooting tip: If detection is difficult, consider that FUT-3 is a Golgi-resident membrane protein, which may require special extraction conditions to maximize solubility.

How should immunohistochemistry protocols be optimized for FUT-3 detection in tissue samples?

For optimal immunohistochemical detection of FUT-3 in tissue samples:

• Fixation: Use 4% paraformaldehyde fixation to preserve antigenicity

• Antigen retrieval: Heat-induced epitope retrieval with citrate buffer (pH 6.0) is typically effective

• Blocking: Block endogenous peroxidase activity with 3% H₂O₂ and non-specific binding with 5% normal serum

• Primary antibody incubation: Use recommended dilutions (typically 1:100-1:500 for IHC) and incubate overnight at 4°C

• Detection system: HRP-conjugated secondary antibodies with DAB substrate provide good contrast

• Cellular localization: Look for specific staining in the Golgi apparatus and Golgi stack membrane, as FUT-3 is a single-pass type II membrane protein

• Controls: Include positive control tissues with known FUT-3 expression and negative controls (primary antibody omission)

Methodological consideration: The subcellular localization pattern should show perinuclear Golgi staining in epithelial cells, particularly in secretory tissues.

What considerations are important for flow cytometric analysis of FUT-3?

When analyzing FUT-3 expression by flow cytometry:

• Cell preparation: Gentle fixation and permeabilization are required as FUT-3 is primarily located in the Golgi apparatus

• Fixation: 2-4% paraformaldehyde followed by permeabilization with 0.1-0.5% saponin preserves Golgi structure

• Antibody selection: Use antibodies validated for flow cytometry applications, such as conjugated monoclonal antibodies

• Controls:

  • Include isotype controls matched to primary antibody

  • Use positive control cell lines (A-549, HT-29)

  • Include FUT-3 negative cells as biological negative controls

• Multi-parameter analysis: Consider co-staining with Golgi markers to confirm proper subcellular localization

• Data interpretation: Account for the typically lower signal intensity of intracellular Golgi proteins compared to surface markers

How should researchers address discrepancies between predicted (42 kDa) and observed (50 kDa) molecular weights of FUT-3?

The discrepancy between the calculated molecular weight of FUT-3 (42 kDa) and its observed migration pattern on SDS-PAGE (50 kDa) is a common source of confusion . This difference can be attributed to:

• Post-translational modifications: FUT-3 is a glycoprotein that undergoes N-linked glycosylation, which increases its apparent molecular weight

• Verification methods:

  • Deglycosylation experiments using PNGase F or other glycosidases should reduce the observed molecular weight

  • Treatment with tunicamycin (inhibits N-glycosylation) in cell culture experiments should produce a lower molecular weight form

  • Mass spectrometry analysis can definitively determine the actual protein mass and modifications

• Research implications: Variations in glycosylation patterns between cell types or disease states may affect the observed molecular weight, potentially serving as a biomarker for certain conditions

When interpreting Western blot results, researchers should expect the 50 kDa band as the primary FUT-3 signal, while considering that altered glycosylation states may produce multiple bands or shifted migration patterns.

What control samples should be included when analyzing FUT-3 expression in experimental studies?

A comprehensive control strategy for FUT-3 expression analysis includes:

For tissue expression studies, gastrointestinal epithelium, lung epithelium, and secretory glands typically express high levels of FUT-3 and serve as excellent positive controls . When studying disease states, always include matched normal tissue samples for comparison.

How can researchers reconcile contradictory results when using different FUT-3 antibodies?

When faced with contradictory results using different FUT-3 antibodies, apply this methodological framework for reconciliation:

• Epitope mapping analysis:

  • Determine the exact epitopes recognized by each antibody

  • Assess whether epitopes might be differentially accessible due to protein folding, complex formation, or post-translational modifications

  • Consider that certain epitopes may be masked in specific cellular compartments

• Validation approaches:

  • Employ orthogonal methods such as qPCR to measure FUT-3 mRNA expression

  • Perform functional enzyme activity assays to measure fucosyltransferase activity

  • Use mass spectrometry for unbiased protein detection and quantification

  • Implement genetic approaches (siRNA knockdown) to confirm antibody specificity

• Biological explanations:

  • Investigate potential splice variants or isoforms of FUT-3

  • Consider post-translational modifications that may affect epitope accessibility

  • Examine whether cellular context influences FUT-3 conformation or interactions

• Technical considerations:

  • Compare antibody performance across different applications (WB vs. IHC vs. ELISA)

  • Evaluate fixation methods, antigen retrieval techniques, and detection systems

  • Consider lot-to-lot variability in antibody production

How can FUT-3 antibodies be used to investigate the role of fucosylation in cancer biology?

FUT-3 antibodies offer powerful tools for investigating fucosylation in cancer through multiple methodological approaches:

• Expression profiling:

  • Comparative analysis of FUT-3 expression between tumor and matched normal tissues using IHC or Western blotting

  • Correlation of FUT-3 expression with clinical parameters through tissue microarray analysis

  • Quantification of FUT-3 in patient serum as a potential biomarker using ELISA

• Mechanistic investigations:

  • Co-immunoprecipitation using FUT-3 antibodies to identify protein interaction partners

  • Immunofluorescence co-localization studies to examine relationships with other glycosyltransferases

  • Analysis of FUT-3 expression changes during epithelial-mesenchymal transition

• Functional studies:

  • Correlation of FUT-3 expression with invasive capacity, metastatic potential, or treatment resistance

  • Evaluation of changes in Lewis antigen expression patterns in response to FUT-3 modulation

  • Assessment of altered glycosylation patterns in cancer stem cells versus differentiated tumor cells

Research has implicated FUT-3-mediated fucosylation in tumor progression through various mechanisms, including immune evasion, altered cell adhesion, and enhanced metastatic potential. FUT-3 antibodies provide vital tools for dissecting these complex processes.

What methodological approaches can be used to study the relationship between FUT-3 and the Lewis blood group system?

To investigate the relationship between FUT-3 and the Lewis blood group system:

• Genotype-phenotype correlation studies:

  • Combine FUT-3 genotyping with antibody-based detection of Lewis antigens

  • Analyze FUT-3 expression in individuals with known Lewis blood group phenotypes

  • Correlate FUT-3 enzyme activity with Lewis antigen expression patterns

• Tissue-specific expression analysis:

  • Compare FUT-3 expression across different tissue types using antibody-based methods

  • Analyze Lewis antigen distribution in tissues using specific anti-Lewis antibodies

  • Correlate FUT-3 expression with Lewis antigen patterns in the same tissues

• Molecular interaction studies:

  • Examine co-localization of FUT-3 with potential glycoprotein and glycolipid substrates

  • Analyze the impact of FUT-3 knockdown or overexpression on Lewis antigen synthesis

  • Investigate regulatory mechanisms controlling FUT-3 expression and activity

• Clinical applications:

  • Examine associations between Lewis antigen expression, FUT-3 levels, and disease susceptibility

  • Investigate the relationship between FUT-3 polymorphisms and Lewis-null phenotypes

  • Analyze the impact of Lewis status on immune responses or pathogen susceptibility

How can FUT-3 antibodies be integrated with glycan analysis for comprehensive glycosylation profiling?

Integration of FUT-3 antibody-based approaches with glycan analysis provides a powerful methodology for comprehensive glycosylation profiling:

For implementing this integrated approach:

• First analyze FUT-3 expression levels using antibody-based methods (Western blot, IHC, ELISA)

• In parallel, perform glycan analysis using techniques such as mass spectrometry or lectin arrays

• Apply bioinformatic approaches to correlate enzyme expression with specific glycan structures

• Validate findings using genetic manipulation (overexpression/knockdown) of FUT-3 followed by glycan profiling

This integrated methodology allows researchers to move beyond correlative observations to establish causal relationships between FUT-3 expression and specific fucosylated glycan structures.

What are the considerations for studying FUT-3 in transplantation immunology?

Recent research has highlighted important roles for antibodies against specific antigens in transplantation contexts. While direct evidence for FUT-3's role remains limited, methodological approaches to investigate this include:

• Examination of pre-transplant auto-antibody profiles:

  • Studies have shown that double positivity for certain auto-antibodies pre-transplant is associated with higher risk of acute rejection with vascular injury

  • Similar methodologies could be applied to study anti-FUT-3 antibodies in transplant recipients

• Transplant rejection mechanism investigation:

  • Analyze FUT-3 expression in rejected organs versus stable grafts

  • Investigate whether fucosylated antigens contribute to immune recognition

  • Examine correlations between donor-recipient FUT-3 polymorphism matching and rejection outcomes

• Therapeutic monitoring applications:

  • Evaluate whether treatments affecting antibody levels (plasma exchange, eculizumab) impact anti-FUT-3 antibodies

  • Monitor changes in fucosylation patterns as potential biomarkers of rejection

This represents an emerging area where FUT-3 antibodies may have both research and clinical applications.

What methodological approaches should be considered when using monoclonal antibody production for custom FUT-3 antibodies?

When considering custom monoclonal antibody production for FUT-3:

• Ethical and scientific considerations:

  • Evaluate in vitro alternatives to ascites methods following regulatory requirements

  • Determine if ascites production is scientifically justified based on specific research needs

  • Implement methods that minimize animal discomfort, distress, and pain

• Immunogen design strategy:

  • Target unique regions of FUT-3 not conserved in other fucosyltransferases

  • Consider using peptides representing functional domains (catalytic region)

  • Include proper carrier proteins for optimal immune response

• Screening methodology:

  • Develop robust screening assays using recombinant FUT-3 protein

  • Implement functional screening to identify antibodies that inhibit enzymatic activity

  • Test cross-reactivity with other fucosyltransferase family members

• Validation requirements:

  • Comprehensive validation using multiple techniques (WB, ELISA, IHC, IF)

  • Testing across various cell types and tissues

  • Evaluation in both native and denatured conditions

Custom antibody production should be pursued only when commercial antibodies cannot meet specific research requirements for epitope specificity, application compatibility, or functional properties.